Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,399 | 390 | 96.8% |
| Education | $280.93 | 28 | 3.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,924 | 91 | $0 (2024) |
| Gilead Sciences, Inc. | $1,110 | 38 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $896.69 | 49 | $0 (2023) |
| Janssen Biotech, Inc. | $851.63 | 44 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $422.49 | 18 | $0 (2024) |
| Ferring Pharmaceuticals Inc. | $383.44 | 25 | $0 (2023) |
| Braintree Laboratories, Inc. | $364.68 | 35 | $0 (2024) |
| Allergan, Inc. | $343.93 | 26 | $0 (2020) |
| Celgene Corporation | $294.66 | 23 | $0 (2024) |
| PFIZER INC. | $244.90 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,223 | 29 | Janssen Biotech, Inc. ($249.15) |
| 2023 | $556.64 | 29 | ABBVIE INC. ($162.01) |
| 2022 | $1,074 | 53 | ABBVIE INC. ($328.46) |
| 2021 | $1,187 | 62 | AbbVie Inc. ($405.39) |
| 2020 | $598.51 | 28 | AbbVie Inc. ($183.12) |
| 2019 | $1,363 | 86 | Braintree Laboratories, Inc. ($249.65) |
| 2018 | $1,177 | 62 | Gilead Sciences, Inc. ($429.87) |
| 2017 | $1,500 | 69 | Gilead Sciences Inc ($250.07) |
All Payment Transactions
418 individual payment records from CMS Open Payments — Page 3 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/21/2023 | CONMED Corporation | CONMED EUS (Device), CONMED BILIARY | Food and Beverage | In-kind items and services | $28.96 | General |
| Category: GENERAL SURGERY | ||||||
| 03/07/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.13 | General |
| Category: Gastroenterology | ||||||
| 02/24/2023 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $11.08 | General |
| Category: VIROLOGY | ||||||
| 02/18/2023 | Ironwood Pharmaceuticals, Inc | Linzess (Drug), Linzess | Food and Beverage | Cash or cash equivalent | $13.89 | General |
| Category: GI | ||||||
| 02/13/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $22.07 | General |
| 02/08/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.81 | General |
| Category: Gastroenterology | ||||||
| 01/27/2023 | NESTLE HEALTHCARE NUTRITION INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $24.16 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 01/03/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $21.49 | General |
| 12/21/2022 | Boston Scientific Corporation | EXALT Model D (Device) | Food and Beverage | In-kind items and services | $20.53 | General |
| Category: EXALT_ENDO | ||||||
| 12/21/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: Gastroenterology | ||||||
| 12/19/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $23.90 | General |
| Category: Gastroenterology | ||||||
| 12/14/2022 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: VIROLOGY | ||||||
| 12/07/2022 | Gilead Sciences, Inc. | Epclusa (Drug) | Food and Beverage | In-kind items and services | $123.97 | General |
| Category: HCV | ||||||
| 12/02/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $21.76 | General |
| Category: Gastroenterology | ||||||
| 11/28/2022 | Nestle HealthCare Nutrition Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $22.41 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 11/23/2022 | Boston Scientific Corporation | WATCHMAN Access System (Device) | Food and Beverage | In-kind items and services | $28.85 | General |
| Category: WATCHMAN_IC | ||||||
| 11/11/2022 | Braintree Laboratories, Inc. | SUTAB (Drug) | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: GI COLON PREP | ||||||
| 10/26/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $23.46 | General |
| Category: IMMUNOLOGY | ||||||
| 10/14/2022 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $22.25 | General |
| Category: Neuroscience | ||||||
| 10/14/2022 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $8.95 | General |
| Category: Neuroscience | ||||||
| 10/12/2022 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $24.18 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/12/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: Gastroenterology | ||||||
| 09/21/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $21.59 | General |
| Category: Gastroenterology | ||||||
| 09/20/2022 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $25.39 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/17/2022 | Nestle HealthCare Nutrition Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $23.92 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 999 | 1,106 | $271,747 | $114,876 |
| 2022 | 15 | 1,237 | 1,422 | $364,813 | $145,999 |
| 2021 | 12 | 1,133 | 1,417 | $359,715 | $147,623 |
| 2020 | 12 | 1,180 | 1,503 | $397,861 | $153,028 |
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 237 | 237 | $41,953 | $28,702 | 68.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 255 | 328 | $36,975 | $25,277 | 68.4% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 152 | 156 | $59,436 | $10,836 | 18.2% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 56 | 56 | $16,057 | $10,652 | 66.3% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 59 | 59 | $18,757 | $8,747 | 46.6% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 97 | 97 | $33,404 | $8,543 | 25.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 60 | 88 | $33,880 | $8,455 | 25.0% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 52 | 52 | $12,439 | $7,702 | 61.9% |
| 43255 | Control of bleeding of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 18 | 20 | $13,308 | $3,177 | 23.9% |
| 45382 | Control of bleeding of upper large bowel using a flexible endoscope | Facility | 2023 | 13 | 13 | $5,539 | $2,785 | 50.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 319 | 463 | $52,186 | $36,625 | 70.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 255 | 255 | $44,769 | $31,292 | 69.9% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 160 | 163 | $62,103 | $13,377 | 21.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 129 | 129 | $46,439 | $11,939 | 25.7% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 54 | 54 | $18,067 | $10,536 | 58.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 85 | 122 | $46,970 | $10,274 | 21.9% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 69 | 69 | $28,447 | $10,244 | 36.0% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 48 | 48 | $14,245 | $7,358 | 51.7% |
| 43255 | Control of bleeding of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 20 | 20 | $12,632 | $3,093 | 24.5% |
| 45382 | Control of bleeding of upper large bowel using a flexible endoscope | Facility | 2022 | 13 | 13 | $5,539 | $2,671 | 48.2% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 21 | 21 | $11,158 | $2,096 | 18.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2022 | 28 | 28 | $5,740 | $1,946 | 33.9% |
| 43246 | Insertion of stomach tube using a flexible endoscope | Facility | 2022 | 11 | 11 | $10,021 | $1,944 | 19.4% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2022 | 13 | 13 | $2,987 | $1,828 | 61.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 12 | 13 | $3,510 | $774.78 | 22.1% |
About Dr. David Elliott, DO
Dr. David Elliott, DO is a Gastroenterology healthcare provider based in Fort Myers, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/17/2005. The National Provider Identifier (NPI) number assigned to this provider is 1811986581.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Elliott, DO has received a total of $8,680 in payments from pharmaceutical and medical device companies, with $1,223 received in 2024. These payments were reported across 418 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($8,399).
As a Medicare-enrolled provider, Elliott has provided services to 4,549 Medicare beneficiaries, totaling 5,448 services with total Medicare billing of $561,525. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Fort Myers, FL
- Active Since 10/17/2005
- Last Updated 03/25/2021
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1811986581
Products in Payments
- STELARA (Biological) $726.43
- XIFAXAN (Drug) $697.14
- Epclusa (Drug) $552.77
- LINZESS (Drug) $351.07
- SKYRIZI (Biological) $323.82
- ZEPOSIA (Drug) $294.66
- ZENPEP (Drug) $277.07
- HUMIRA (Biological) $276.17
- Humira (Biological) $253.45
- TREMFYA (Drug) $249.15
- PREPOPIK (Drug) $241.92
- Creon (Drug) $234.00
- VIBERZI (Drug) $207.00
- ENTYVIO (Biological) $202.21
- SUPREP BOWEL PREP (Drug) $192.08
- MAVYRET (Drug) $181.74
- Cologuard Collection Kit (Device) $177.04
- VOQUEZNA (Drug) $135.72
- Da Vinci Surgical System (Device) $132.32
- CLENPIQ (Drug) $122.69
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Fort Myers
Randall Jacobs, Md, MD
Gastroenterology — Payments: $18,306
Juan Tejada-Almonte, M.d, M.D
Gastroenterology — Payments: $13,404
Dr. Augustine Salami, Md, MD
Gastroenterology — Payments: $10,902
Dr. Edward Jurkovic, D.o, D.O
Gastroenterology — Payments: $9,721
Robert Janda, Md, MD
Gastroenterology — Payments: $8,904
Ramesh Koka, M.d, M.D
Gastroenterology — Payments: $8,404